Eustacia Pharmaceuticals Private Limited
About Eustacia Pharmaceuticals Private Limited
Data last updated:
Eustacia Pharmaceuticals Private Limited is a private limited company based in Narigapalli, Andhra Pradesh, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 07 April 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U51909AP2016PTC103081. Its GSTIN is 05AAECE2442F1Z4 (Uttarakhand).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manoj Kumar (Managing Director) and Vinod Kumar.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at D – No 37 – 514 Gopalapuram, Narigapalli, Andhra Pradesh, India – 517002.
As per the financials filed for FY 2020, the company reported a revenue of ₹9.3 Lakh, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹28,256 (net margin 3%) and EBITDA of ₹43,624 (EBITDA margin 4.7%). Revenue has grown at a compounded annual rate (CAGR) of 41% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Eustacia Pharmaceuticals Private Limited's registered office is in Narigapalli, Andhra Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressD – No 37 – 514 Gopalapuram, Narigapalli, Andhra Pradesh, India – 517002
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Eustacia Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Eustacia Pharmaceuticals Private Limited
FY 2020 filings availableEustacia Pharmaceuticals Private Limited reported revenue of ₹9.3 Lakh (up 22% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 41% over three years, including 22% growth in the latest year. EBITDA rose 133% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ₹9.3 Lakh | |||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹43,624 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹28,256 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 4.7% | |||
| Net Profit Margin | 3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Eustacia Pharmaceuticals Private Limited, buy the company report.
Board of directors of Eustacia Pharmaceuticals Private Limited
Eustacia Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vinod Kumar | Director | 07 Apr 2016 | 10 Years 6 Months | Current |
| Manoj Kumar Also directs: Garvin Genetics Limited | Managing Director | 07 Apr 2016 | 10 Years 6 Months | Current |
Auditor
Eustacia Pharmaceuticals Private Limited is audited by RAMANKUMARSAH for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAMANKUMARSAH | FY 2017 | 531865 |
Shareholding
The shareholding of Eustacia Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Eustacia Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Eustacia Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Eustacia Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Eustacia Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAECE2442F1Z4 | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Eustacia Pharmaceuticals Private Limited, buy the company report.
Recent activity
Eustacia Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Manoj Kumar was appointed as Managing Director on 07 Apr 2016.
Frequently asked questions
Eustacia Pharmaceuticals is an active private limited company based in Narigapalli, Andhra Pradesh, India. The company works in chemical products, within the chemicals industry. It was incorporated on 07 April 2016 (10+ years old) and is registered under CIN U51909AP2016PTC103081.
Eustacia Pharmaceuticals has 2 current directors:
- Manoj Kumar - Managing Director
- Vinod Kumar - Director
The latest financial statements of Eustacia Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Eustacia Pharmaceuticals is 05AAECE2442F1Z4, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Eustacia Pharmaceuticals is U51909AP2016PTC103081. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eustacia Pharmaceuticals was incorporated on 07 April 2016, making it 10+ years old. It is registered with the Registrar of Companies, Vijayawada.
Manoj Kumar was appointed as Managing Director on 07 Apr 2016. Vinod Kumar was appointed as Director on 07 Apr 2016.
The registered office of Eustacia Pharmaceuticals is at D – No 37 – 514 Gopalapuram, Narigapalli, Andhra Pradesh, India – 517002.
Eustacia Pharmaceuticals operates in the chemicals industry, in the chemical products segment.
The compliance status of Eustacia Pharmaceuticals is compliant as of 11 September 2026. The company is actively filing with the Registrar of Companies.